Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97093464 | 9709346 | 4 | F | 2012 | 20160720 | 20131125 | 20160725 | EXP | BR-AMGEN-BRASP2013082476 | AMGEN | 61.00 | YR | A | F | Y | 70.00000 | KG | 20160725 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97093464 | 9709346 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, ONCE WEEKLY | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 97093464 | 9709346 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, ONCE WEEKLY | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 97093464 | 9709346 | 3 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50MG 2X/WEEK | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | BIW | ||||||
| 97093464 | 9709346 | 4 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | 112 MG, UNK | 0 | 112 | MG | |||||||||
| 97093464 | 9709346 | 5 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | 0 | ||||||||||||
| 97093464 | 9709346 | 6 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
| 97093464 | 9709346 | 7 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
| 97093464 | 9709346 | 8 | C | DORFLEX | CAFFEINEDIPYRONEORPHENADRINE | 1 | UNK | 0 | |||||||||||
| 97093464 | 9709346 | 9 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 97093464 | 9709346 | 10 | C | DOMPERIDONE | DOMPERIDONE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 97093464 | 9709346 | 11 | C | SIMETHICONE (DIMETHICONE) | DIMETHICONE | 1 | 125 MG, UNK | 0 | 125 | MG | |||||||||
| 97093464 | 9709346 | 12 | C | SERTRALINE HYDROCHLORIDE. | SERTRALINE HYDROCHLORIDE | 1 | 50 MG, UNK | 0 | 50 | MG | |||||||||
| 97093464 | 9709346 | 13 | C | VALINA | 2 | 5 MG, UNK | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97093464 | 9709346 | 1 | Psoriasis |
| 97093464 | 9709346 | 4 | Hyperthyroidism |
| 97093464 | 9709346 | 5 | Hypothyroidism |
| 97093464 | 9709346 | 8 | Headache |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97093464 | 9709346 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97093464 | 9709346 | Arthralgia | |
| 97093464 | 9709346 | Condition aggravated | |
| 97093464 | 9709346 | Disease recurrence | |
| 97093464 | 9709346 | Drug ineffective | |
| 97093464 | 9709346 | Erythema | |
| 97093464 | 9709346 | Joint range of motion decreased | |
| 97093464 | 9709346 | Psoriasis | |
| 97093464 | 9709346 | Psoriatic arthropathy | |
| 97093464 | 9709346 | Skin lesion | |
| 97093464 | 9709346 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 97093464 | 9709346 | 1 | 20120930 | 201303 | 0 | |
| 97093464 | 9709346 | 2 | 201308 | 0 | ||
| 97093464 | 9709346 | 3 | 201508 | 0 | ||
| 97093464 | 9709346 | 4 | 1991 | 0 | ||
| 97093464 | 9709346 | 8 | 2010 | 0 |